Sezer ED, Sozmen EY, Nart D, Onat T (2011) <br />Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation<br /><i>Vasc Health Risk Manag</i> <b>7</b>: 333<br /><br />Kayikcioglu M, Saygi S, Azarsiz E, Can LH, Kultursay H, Sozmen EY (2007) <br />Serum paraoxonase 1 activity and oxidative markers of LDL in patients with cardiac syndrome X<br /><i>Acta Cardiol</i> <b>62</b>: 245<br /><br />Sozmen B, Peker S, Kaya U, Erkan M, Sozmen EY (2007) <br />Markers of long-term exposure to organophosphorus pesticides in farmers who work in viniculture and tobacco production in Turkey<br /><i>Toxicol Mech Methods</i> <b>17</b>: 379<br /><br />Akcay YD, Sagin FG, Sendag F, Oztekin K, Sozmen EY (2006) <br />Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?<br /><i>Maturitas</i> <b>53</b>: 325<br /><br />Ak G, Ozgonul M, Sozmen EY, Aslan SL, Sozmen B (2002) <br />Renal cortical thickness and PON1 activity both decrease in chronic renal failure<br /><i>J Nephrol</i> <b>15</b>: 144<br /><br />Sozmen EY, Mackness B, Sozmen B, Durrington P, Girgin FK, Aslan L, Mackness MI (2002) <br />Effect of organophosphate intoxication on human serum paraoxonase<br /><i>Hum Exp Toxicol</i> <b>21</b>: 247<br /><br />Sozmen EY, Sozmen B, Delen Y, Onat T (2001) <br />Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control<br /><i>Arch Med Res</i> <b>32</b>: 283<br /><br />Sozmen EY, Sozmen B, Girgin FK, Delen Y, Azarsiz E, Erdener D, Ersoz B (2001) <br />Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation<br /><i>Clin Exp Med</i> <b>1</b>: 195<br /><br />Akgur SA, Ozturk P, Sozmen EY, Delen Y, Tanyalcin T, Ege B (1999) <br />Paraoxonase and acetylcholinesterase activities in humans exposed to organophosphorous compounds<br /><i>J Toxicol Environ Health</i> <b>58</b>: 469<br /><br />Sozmen B, Delen Y, Girgin FK, Sozmen EY (1999) <br />Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control<br /><i>Clinical Biochemistry</i> <b>32</b>: 423<br /><br />